Integrated marketing and communications consultancy, bcsAgency has added to its growing portfolio of pharmaceutical clients with a new contract from US-based Octagon Research Solutions, Inc. (Octagon).
Octagon is the industry leader in transforming clinical R&D through an integrated suite of regulatory, clinical, process and technology solutions. In January 2006, Octagon established an office in theUK, and in February 2012 launched an expansion programme appointing the bcsAgency to implement an integrated PR, digital and marketing campaign incorporating social media and digital advertising along with strategy and consultancy work.
Murray Carmichael-Smith, director of bcsAgency, commented: “Our initial work with Octagon to scope out their requirements within Europe and select the most appropriate channels and targets for our activity has paid dividends. We have become a valuable extension to the Octagon global marketing team and are making great strides in communicating the company’s industry leadership position.”
The addition of Octagon as a client adds to bcsAgency’s significant experience in the pharmaceutical sector, having worked with companies including Quotient Bioresearch, the Medical Research Network, Novozymes Biopharma, the Institute of Clinical Research, Chiltern International and Perceptive Informatics.
Ellen Semple, senior director of global marketing at Octagon, said: “The bcsAgency team has been extremely responsive and helpful in partnering with us to help enhance our marketing and communications plans for Europe and we have truly valued their understanding of the European pharmaceutical market.”
bcsAgency is an integrated marketing and communications consultancy that delivers online and offline campaigns including PR, social media strategy, website and mobile, direct mail, design and advertising to its national and international clients.
For information about bcsAgency’s portfolio of services and client experience, visit the website at www.bcsagency.com.